呋喃妥因 (Furadantin, Macrobid, Macrodantin)

Nitrofurantoin

生产企业：Watson laboratories inc, Shionogi pharma inc，另有 8 家

Nitrofurantoin is an antibiotic used to treat urinary tract infections.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Nitrofurantoin is an antibiotic used to treat urinary tract infections.

作用机制

Nitrofurantoin is converted by bacterial nitroreductases to electrophilic intermediates which inhibit the citric acid cycle as well as synthesis of DNA, RNA, and protein.

适应症

Nitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Combination comprising zidovudine and an antimicrobial compound
US 11951119 B2申请人: HELPERBY THERAPEUTICS LTD优先权: 2018
CN
US
2 件公开
Compositions comprising nitrofurantoin and uva ursi
US 6521270 B1申请人: PROCTER & GAMBLE优先权: 2002
US
2 件公开
Use of a standardised dry extract of leaves of Buddleja globosa hope, BG-126, for the treatment and prevention of gastrointestinal disorders caused by treatment with nitrofurantoin and other antimicrobials
US 8852654 B2申请人: LETELIER MUNOZ MARIA EUGENIA优先权: 2011
US
2 件公开
Topical antimicrobial compositions and methods of formulating the same
US 11446236 B2申请人: CMPD LICENSING LLC优先权: 2019
US
2 件公开
External application medicine for treating sweaty feet with bromidrosis
CN 1163250 C申请人: CHEN JIELI优先权: 2000
CN
Nitrofurantoin controlled release dosage form
US 2006002997 A1申请人: SHAMAR PUNEET优先权: 2002
US
Externally applied medicine for treating beriberi and sweaty feet
CN 1606991 A申请人: XIONG YONGZHONG优先权: 2003
CN
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US 2005202079 A1申请人: MYLAN PHARMACEUTICALS INC优先权: 2004
US
Method for producing cistofuran monohydrate
CN 101450942 A申请人: SHANDONG FANGXING SCIENCE AND优先权: 2007
CN
Cistofuran synthesis and purification method
CN 101450941 A申请人: SHANDONG FANGXING SCIENCE AND优先权: 2007
CN

药物

呋喃妥因 (Furadantin, Macrobid, Macrodantin)

概览

作用机制

适应症

相关疾病

专利